Marksans Pharma has informed about half yearly Compliance Certificate pursuant to Regulation 40 (9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. This information pertains to half year ended March 31, 2018.
The above information is a part of company’s filings submitted to BSE.